Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. 2009

Jasper G van den Boorn, and Debby Konijnenberg, and Trees A M Dellemijn, and J P Wietze van der Veen, and Jan D Bos, and Cornelis J M Melief, and Florry A Vyth-Dreese, and Rosalie M Luiten
Department of Dermatology, Netherlands Institute for Pigment Disorders, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

In vitiligo, cytotoxic T cells infiltrating the perilesional margin are suspected to be involved in the pathogenesis of the disease. However, it remains to be elucidated whether these T cells are a cause or a consequence of the depigmentation process. T cells we obtained from perilesional skin biopsies, were significantly enriched for melanocyte antigen recognition, compared with healthy skin-infiltrating T cells, and were reactive to melanocyte antigen-specific stimulation. Using a skin explant model, we were able to dissect the in situ activities of perilesional T cells in the effector phase of depigmentation. We show that these T cells could infiltrate autologous normally pigmented skin explants and efficiently kill melanocytes within this microenvironment. Interestingly, melanocyte apoptosis was accompanied by suprabasal keratinocyte apoptosis. Perilesional T cells did, however, not induce apoptosis in lesional skin, which is devoid of melanocytes, indicating the melanocyte-specific cytotoxic activity of these cells. Melanocyte killing correlated to local infiltration of perilesional T cells. Our data show that perilesional cytotoxic T cells eradicate pigment cells, the characteristic hallmark of vitiligo, thereby providing evidence of T cells being able to mediate targeted autoimmune tissue destruction.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008544 Melanocytes Mammalian pigment cells that produce MELANINS, pigments found mainly in the EPIDERMIS, but also in the eyes and the hair, by a process called melanogenesis. Coloration can be altered by the number of melanocytes or the amount of pigment produced and stored in the organelles called MELANOSOMES. The large non-mammalian melanin-containing cells are called MELANOPHORES. Melanocyte
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014820 Vitiligo A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.
D015551 Autoimmunity Process whereby the immune system reacts against the body's own tissues. Autoimmunity may produce or be caused by AUTOIMMUNE DISEASES. Autoimmune Response,Autoimmune Responses,Autoimmunities
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D020381 Interleukin-17 A proinflammatory cytokine produced primarily by T-LYMPHOCYTES or their precursors. Several subtypes of interleukin-17 have been identified, each of which is a product of a unique gene. IL-17,CTLA-8,CTLA8,Cytokine CX2,Cytokine ML-1,Cytotoxic T lymphocyte-Associated Antigen 8,IL-17A,IL-17B,IL-17C,IL-17E,IL-17F,Interleukin 17,Interleukin-17A,Interleukin-17B,Interleukin-17C,Interleukin-17E,Interleukin-17F,Interleukin-25,CX2, Cytokine,Cytokine ML 1,Cytotoxic T lymphocyte Associated Antigen 8,IL 17E,Interleukin 17A,Interleukin 17B,Interleukin 17C,Interleukin 17E,Interleukin 17F,Interleukin 25

Related Publications

Jasper G van den Boorn, and Debby Konijnenberg, and Trees A M Dellemijn, and J P Wietze van der Veen, and Jan D Bos, and Cornelis J M Melief, and Florry A Vyth-Dreese, and Rosalie M Luiten
April 2015, Archives of dermatological research,
Jasper G van den Boorn, and Debby Konijnenberg, and Trees A M Dellemijn, and J P Wietze van der Veen, and Jan D Bos, and Cornelis J M Melief, and Florry A Vyth-Dreese, and Rosalie M Luiten
August 2000, Laboratory investigation; a journal of technical methods and pathology,
Jasper G van den Boorn, and Debby Konijnenberg, and Trees A M Dellemijn, and J P Wietze van der Veen, and Jan D Bos, and Cornelis J M Melief, and Florry A Vyth-Dreese, and Rosalie M Luiten
January 2013, Molecular medicine reports,
Jasper G van den Boorn, and Debby Konijnenberg, and Trees A M Dellemijn, and J P Wietze van der Veen, and Jan D Bos, and Cornelis J M Melief, and Florry A Vyth-Dreese, and Rosalie M Luiten
November 1995, The Journal of investigative dermatology,
Jasper G van den Boorn, and Debby Konijnenberg, and Trees A M Dellemijn, and J P Wietze van der Veen, and Jan D Bos, and Cornelis J M Melief, and Florry A Vyth-Dreese, and Rosalie M Luiten
August 2001, Laboratory investigation; a journal of technical methods and pathology,
Jasper G van den Boorn, and Debby Konijnenberg, and Trees A M Dellemijn, and J P Wietze van der Veen, and Jan D Bos, and Cornelis J M Melief, and Florry A Vyth-Dreese, and Rosalie M Luiten
August 2006, Autoimmunity reviews,
Jasper G van den Boorn, and Debby Konijnenberg, and Trees A M Dellemijn, and J P Wietze van der Veen, and Jan D Bos, and Cornelis J M Melief, and Florry A Vyth-Dreese, and Rosalie M Luiten
December 2008, Photodermatology, photoimmunology & photomedicine,
Jasper G van den Boorn, and Debby Konijnenberg, and Trees A M Dellemijn, and J P Wietze van der Veen, and Jan D Bos, and Cornelis J M Melief, and Florry A Vyth-Dreese, and Rosalie M Luiten
June 2009, Journal of dermatological science,
Jasper G van den Boorn, and Debby Konijnenberg, and Trees A M Dellemijn, and J P Wietze van der Veen, and Jan D Bos, and Cornelis J M Melief, and Florry A Vyth-Dreese, and Rosalie M Luiten
December 2016, Journal of clinical and diagnostic research : JCDR,
Jasper G van den Boorn, and Debby Konijnenberg, and Trees A M Dellemijn, and J P Wietze van der Veen, and Jan D Bos, and Cornelis J M Melief, and Florry A Vyth-Dreese, and Rosalie M Luiten
April 2008, Pigment cell & melanoma research,
Copied contents to your clipboard!